Neuromodulation for Lennox-Gastaut Syndrome: Interview with Martha Morrell, M.D., CMO of NeuroPace
NeuroPace, a medtech company based in California, has developed the RNS system, an implantable neuromodulation device for focal drug-resistant epilepsy. The system continuously monitors brain activity and then responds appropriately to target the seizure source in the brain fo...
Read more